Copyright Reports & Markets. All rights reserved.

Global Neurodegenerative Disease Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Neurodegenerative Disease Market Overview

      • 1.1 Product Overview and Scope of Neurodegenerative Disease
      • 1.2 Neurodegenerative Disease Segment by Type
        • 1.2.1 Global Neurodegenerative Disease Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 NMDA
        • 1.2.3 SSRIs
        • 1.2.4 Dopamine Inhibitors
      • 1.3 Neurodegenerative Disease Segment by Application
        • 1.3.1 Neurodegenerative Disease Consumption Comparison by Application (2014-2025)
        • 1.3.2 Parkinson’s Disease
        • 1.3.3 Huntington Disease
        • 1.3.4 Amyotrophic Lateral Sclerosis
        • 1.3.5 Alzheimer’s Disease
      • 1.4 Global Neurodegenerative Disease Market by Region
        • 1.4.1 Global Neurodegenerative Disease Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Neurodegenerative Disease Market Size
        • 1.5.1 Global Neurodegenerative Disease Revenue (2014-2025)
        • 1.5.2 Global Neurodegenerative Disease Production (2014-2025)

      2 Global Neurodegenerative Disease Market Competition by Manufacturers

      • 2.1 Global Neurodegenerative Disease Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Neurodegenerative Disease Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Neurodegenerative Disease Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Neurodegenerative Disease Production Sites, Area Served, Product Types
      • 2.5 Neurodegenerative Disease Market Competitive Situation and Trends
        • 2.5.1 Neurodegenerative Disease Market Concentration Rate
        • 2.5.2 Neurodegenerative Disease Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Neurodegenerative Disease Production Market Share by Regions

      • 3.1 Global Neurodegenerative Disease Production Market Share by Regions
      • 3.2 Global Neurodegenerative Disease Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Neurodegenerative Disease Production
        • 3.4.1 North America Neurodegenerative Disease Production Growth Rate (2014-2019)
        • 3.4.2 North America Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Neurodegenerative Disease Production
        • 3.5.1 Europe Neurodegenerative Disease Production Growth Rate (2014-2019)
        • 3.5.2 Europe Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Neurodegenerative Disease Production (2014-2019)
        • 3.6.1 China Neurodegenerative Disease Production Growth Rate (2014-2019)
        • 3.6.2 China Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Neurodegenerative Disease Production (2014-2019)
        • 3.7.1 Japan Neurodegenerative Disease Production Growth Rate (2014-2019)
        • 3.7.2 Japan Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Neurodegenerative Disease Consumption by Regions

      • 4.1 Global Neurodegenerative Disease Consumption by Regions
      • 4.2 North America Neurodegenerative Disease Consumption (2014-2019)
      • 4.3 Europe Neurodegenerative Disease Consumption (2014-2019)
      • 4.4 China Neurodegenerative Disease Consumption (2014-2019)
      • 4.5 Japan Neurodegenerative Disease Consumption (2014-2019)

      5 Global Neurodegenerative Disease Production, Revenue, Price Trend by Type

      • 5.1 Global Neurodegenerative Disease Production Market Share by Type (2014-2019)
      • 5.2 Global Neurodegenerative Disease Revenue Market Share by Type (2014-2019)
      • 5.3 Global Neurodegenerative Disease Price by Type (2014-2019)
      • 5.4 Global Neurodegenerative Disease Production Growth by Type (2014-2019)

      6 Global Neurodegenerative Disease Market Analysis by Applications

      • 6.1 Global Neurodegenerative Disease Consumption Market Share by Application (2014-2019)
      • 6.2 Global Neurodegenerative Disease Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Neurodegenerative Disease Business

      • 7.1 Novartis
        • 7.1.1 Novartis Neurodegenerative Disease Production Sites and Area Served
        • 7.1.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.1.3 Novartis Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Pfizer
        • 7.2.1 Pfizer Neurodegenerative Disease Production Sites and Area Served
        • 7.2.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.2.3 Pfizer Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Merck Serono
        • 7.3.1 Merck Serono Neurodegenerative Disease Production Sites and Area Served
        • 7.3.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.3.3 Merck Serono Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Biogen Idec
        • 7.4.1 Biogen Idec Neurodegenerative Disease Production Sites and Area Served
        • 7.4.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.4.3 Biogen Idec Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 TEVA
        • 7.5.1 TEVA Neurodegenerative Disease Production Sites and Area Served
        • 7.5.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.5.3 TEVA Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 UCB
        • 7.6.1 UCB Neurodegenerative Disease Production Sites and Area Served
        • 7.6.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.6.3 UCB Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Boehringer Ingelheim
        • 7.7.1 Boehringer Ingelheim Neurodegenerative Disease Production Sites and Area Served
        • 7.7.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.7.3 Boehringer Ingelheim Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sanofi
        • 7.8.1 Sanofi Neurodegenerative Disease Production Sites and Area Served
        • 7.8.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.8.3 Sanofi Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlaxoSmithKline
        • 7.9.1 GlaxoSmithKline Neurodegenerative Disease Production Sites and Area Served
        • 7.9.2 Neurodegenerative Disease Product Introduction, Application and Specification
        • 7.9.3 GlaxoSmithKline Neurodegenerative Disease Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Neurodegenerative Disease Manufacturing Cost Analysis

      • 8.1 Neurodegenerative Disease Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Neurodegenerative Disease
      • 8.4 Neurodegenerative Disease Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Neurodegenerative Disease Distributors List
      • 9.3 Neurodegenerative Disease Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Neurodegenerative Disease Market Forecast

      • 11.1 Global Neurodegenerative Disease Production, Revenue Forecast
        • 11.1.1 Global Neurodegenerative Disease Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Neurodegenerative Disease Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Neurodegenerative Disease Price and Trend Forecast (2019-2025)
      • 11.2 Global Neurodegenerative Disease Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Neurodegenerative Disease Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Neurodegenerative Disease Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Neurodegenerative Disease Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Neurodegenerative Disease Production, Revenue Forecast (2019-2025)
      • 11.3 Global Neurodegenerative Disease Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Neurodegenerative Disease Consumption Forecast (2019-2025)
        • 11.3.2 Europe Neurodegenerative Disease Consumption Forecast (2019-2025)
        • 11.3.3 China Neurodegenerative Disease Consumption Forecast (2019-2025)
        • 11.3.4 Japan Neurodegenerative Disease Consumption Forecast (2019-2025)
      • 11.4 Global Neurodegenerative Disease Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Neurodegenerative Disease Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss.

        The global Neurodegenerative Disease market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Neurodegenerative Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Novartis
        Pfizer
        Merck Serono
        Biogen Idec
        TEVA
        UCB
        Boehringer Ingelheim
        Sanofi
        GlaxoSmithKline

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        NMDA
        SSRIs
        Dopamine Inhibitors

        Segment by Application
        Parkinson’s Disease
        Huntington Disease
        Amyotrophic Lateral Sclerosis
        Alzheimer’s Disease

        Buy now